In a strategic move to enhance healthcare delivery, the NHS has announced plans to intensify the utilisation of virtual wards under the the Urgent and
Emergency Care Recovery Plan.
The NHS virtual wards are aimed to reduce avoidable hospital admissions across England.
This follows a comprehensive analysis revealing significant benefits from virtual wards over the past year.
"Virtual wards offer a transformative approach to healthcare delivery, allowing patients to receive medical care from the comfort of their own homes," remarked
NHS national director for urgent and emergency care, Sarah-Jane Marsh.
"This initiative not only reduces the burden on hospital resources but also ensures that patients receive timely and personalised care."
NHS England has confirmed the initial sites that will test and implement Martha's Rule in the first phase of the programme.
This follows the announcement in February regarding NHSE funding for the major patient safety initiative for this financial year.
The scheme is named after Martha Mills, who died from sepsis at the age of 13 in 2021. She had been treated at King's College Hospital, London, where a failure
to escalate her to intensive care and a lack of response to her family's concerns about her deteriorating condition contributed to her death.
Martha's Rule aims to provide a consistent and understandable way for patients and families to seek an urgent review if their or their loved one's condition
deteriorates and they are concerned this is not being responded to.
NHS England on Monday (27 May) announced that the scheme will be implemented at 143 hospital sites across the country by March 2025.
Matthew Taylor, Chief Executive of the NHS Confederation, delivered a compelling speech at the NHS ConfedExpo 2024, emphasising the critical need for
investment in community-based care and the revitalisation of primary care services.
In his address, Taylor also criticised the current health policy as "not fit for purpose," calling for radical changes to shift the NHS from a reactive to a
proactive health model.
Addressing delegates at the Manchester event, Taylor highlighted the importance of shifting resources towards prevention and community services.
Underscoring a strategic pivot from reactive to proactive health models, he said:
"We must see action to fulfil the long-held vision of a health service that invests better upstream in prevention, in primary and in community-based care."
A diabetes medicine, Mounjaro, has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) to treat overweight patients.
The weight loss medication originally developed for Type 2 diabetes is now accessible to individuals aged 18 and over who are dealing with obesity and
weight-related health issues.
The active ingredient, tirzepatide, works by making the patient feel fuller and reducing food cravings.
The injection helps individuals lose 20 per cent of their body weight, and are advised to follow a reduced-calorie diet and increase physical activity
simultaneously.
Although it is not authorised to use on the NHS as yet but future approvals can be predicted.
In 2023, almost 14,000 people in England are estimated to have died due to excessive waits in emergency departments, averaging more than 260 deaths per week,
according to new figures from the Royal College of Emergency Medicine (RCEM).
The RCEM estimate is based on a large study of NHS patients published in the Emergency Medicine Journal in 2021, which found one excess death for every 72 patients
who spent eight to 12 hours in an A&E department.
Following a Freedom of Information audit of NHS trusts, the college has found that 65 per cent of people waiting 12 hours or more in A&E were patients waiting for
a hospital bed.
NHS data for England revealed that over 1.5 million patients waited 12 hours or more in major emergency departments last year. Based on the RCEM calculation, this
indicates that over a million of those patients were waiting for a bed.
In a bid to address the ongoing deficit in staff in the UK's healthcare system, the National Health Service (NHS) has entered into a new workforce agreement
with India.
According to media reports, the healthcare service plans to hire 2,000 doctors from India on a fast-track basis to alleviate this pressing issue.
It is learned that the NHS has set up training centres across many Indian cities such as Mumbai, Bangalore, Nagpur, Delhi, Gurugram, Indore, Mysore, Chennai,
and Calicut to provide postgraduate training for the first batch of doctors.
Post their training period (which ranges from six to 12 months), these doctors will be deployed at hospitals across Britain. They will also be exempted from the
Professional and Linguistic Assessments Board (PLAB) examination that is otherwise mandatory for practising in the country.
Darren Jones MP, the Shadow Chief Secretary to the Treasury, visited Sigma Pharmaceuticals plc's new Watford facility on Thursday (6 June) as part of the
imminent Labour Party campaign trail.
Jones was joined by Labour's prospective parliamentary candidate for Watford, Matt Turmaine, and a team of campaign workers.
During their visit, the Labour delegation met with the directors and founding member of Sigma, Dr Bharat Shah CBE, and discussed the importance of investment
and support for growing businesses and the pharmaceutical sector both in the region and across the country.
Sigma Pharmaceuticals, which is believed to be Watford's largest employer, noted that the pharmaceutical sector contributes a significant value to the East of
England, accounting for 12.3 per cent of the region's manufacturing gross value added (GVA).
According to a report in 'The Mirror', palliative care doctors see hundreds of people dying in front of them. One of these doctors has revealed how a person feels before death. When a person dies, what is the reaction of his body and what is going on in his mind. Experts have limited information about this process, but the truth is that death awaits the person who has already died.
WBA, Boots parent company revealed the results for its fourth quarter of the financial year, showing three months to August 2023.
The reports published on 12 October show the loss of at least $1bn following a net loss of $3.1bn on an annual basis. This marks a decrease compared to a profit
of $4.3bn in the previous financial year.
The loss was attributed in part to a $5.5 billion after-tax charge related to opioid claims and litigation during the period, as well as the comparison against a
$2.5 billion after-tax gain from the company's investments in Village MD and Shields Health Solutions in the same period last year.
Ginger Graham, WBA's Interim Chief Executive spoke about the company's performance and its dedication to their customers and patients.
Consumer healthcare group Haleon on Thursday announced that it has entered into a binding agreement for the sale of the ChapStick brand to Suave Brands
Company, a company owned by American private equity firm Yellow Wood Partners.
The British consumer healthcare company has agreed to sell its lip balm brand to Suave for about $430 million in cash and a minority interest in the buyer,
valued at around $80 million.
Haleon, which was spun off from the GSK Group in July 2022, said that cash proceeds from the sale would be used to pay down debt.
ChapStick generated £112 million ($142.5 million) in revenue in 2023, said Haleon, adding that the sale is likely to close in the second quarter of 2024.
Brian McNamara, Chief Executive Officer, Haleon, said: "Today's announcement is consistent with Haleon being proactive in managing our portfolio, and being
rigorous and disciplined where there are opportunities for divestment.
"While ChapStick is a great brand, much loved by consumers around the world, it is not a core focus for Haleon.
It has been reported that several Austrians have been taken to the hospital after injecting fake Ozempic, as confirmed by health regulator.
Austria's Federal Office for Safety in Health Care (BASG) confirmed that the patients have suffered hypoglycaemia and seizures.
It is believed that the injections contained insulin instead of the weight loss drug, semaglutide.
The health regulator has urged doctors and patients to verify their medication stocks.
The British Generic Manufacturers Association (BGMA) has warned that England's 42 integrated care boards (ICBs) may need to allocate an extra £37 million
from their budgets annually for the next five years due to the spiralling tax rates.
The government's Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) rebate rate increased more than five-fold in the past two years, the BGMA said
in its white paper released on Monday (October 30).
The report, conducted by consultancy firm Conclusio in consultation with local NHS leaders, examined the potential effects of the VPAS on ICB budgets.
BGMA said that due to the elevated VPAS rate, each ICB in England will experience significant increases in expenses for branded generics and biosimilars
annually - a consequence of reduced competition.
The Royal Pharmaceutical Society (RPS) has said that multi-buy deals on paracetamol violate the existing voluntary sales guidelines.
The professional body is urging the government to pass legislation that prohibits retailers from making such offers on medicines for pain relief.
They have also sent letters to MP Maria Caulfield who is the Minister for Mental Health and Women's Health.
The Medicines and Healthcare Products Regulatory Agency (MHRA) is requesting to take action on the legislation at the earliest.
The concern raised is that multi-buy offers such as 'buy one get one free' can encourage people to buy and store excess packs, which may lead to accidental
or impulsive overdose.
The government has allocated an additional 350 medical school places in England, making a significant step in delivering the NHS Long Term Workforce Plan.
Supported by more than £2.4 billion in government funding, the plan outlines the strategy for recruiting and retaining hundreds of thousands more staff over the
next 15 years to deliver the future workforce the NHS requires.
One of the key commitments of the NHS Long Term Workforce Plan is to double the number of medical school places in England to 15,000 by 2031.
As part of the ongoing efforts to fulfill this pledge, the Office for Students (OfS) has designated 350 places for medical schools nationwide for the academic year
2025 to 2026, targeting under-doctored areas.
The Medicines and Healthcare products Regulatory Agency (MHRA) has advised the public to exercise caution when buying anti-choking devices online,
ensuring these products are purchased from reputable sellers.
As estimated by the regulator, more than 10,000 counterfeit or unbranded anti-choking devices have been purchased by the public within the last two years through
listings on online marketplaces such as Amazon and eBay, as well as drop-shipping websites.
People are cautioned that the use of such products poses a substantial risk of failure in clearing blockages and could exacerbate the situation by pushing
obstructions further down into the airway passage.
Dr Alison Cave, MHRA Chief Safety Officer, said: "Buying anti-choking devices that do not have a valid UKCA or CE mark increases the risk of receiving a product
which does not include appropriate instructions and is either fake or does not meet the UK's regulatory requirements.
"These products do not meet our strict quality standards and may put your health and safety at significant risk by failing to resolve or even worsening choking
incidents."
Part of a raft of National Health Services (NHS) measures which aim to support people to prevent or reduce incidence of type 2 diabetes and obesity, the
NHS Digital Weight Management Programme has emerged as a beacon of success in the battle against obesity, with a recent study showcasing its effectiveness in
aiding weight loss among participants.
According to research published in The Obesity Journal, the programme has garnered significant traction, with over 63,000 individuals referred in its inaugural year.
Encouragingly, half of those referred opted to enroll in the service, highlighting its appeal and accessibility.
Among the 14,000 participants who completed the 12-week programme between April 2021 and March 2022, a notable average weight loss of 3.9kg (equivalent to 8.59lbs)
was achieved.
Even among those who did not complete the programme, an average weight loss of 2.2kg (approximately 4.85lbs) was observed.
The final report of the Infected Blood Inquiry has been published today, bringing to light a devastating chapter in the history of the UK's healthcare system.
The inquiry, which was launched by former Prime Minister Theresa May in 2017, examined how contaminated blood products infected over 30,000 NHS patients with
deadly viruses, including HIV and Hepatitis C, between the 1970s and 1990s.
Following the publication of the report, Prime Minister Rishi Sunak issued a formal apology on behalf of successive governments, acknowledging the state's
significant failings.
He stated that he finds it "impossible to comprehend" how victims felt when injected with deadly diseases through no fault of their own.
To combat 14 years of Tory neglect, Labour Party under the leadership of Keir Starmer has revealed plan to create "healthiest generation of children", ahead
of the general elections.
The broader mission includes shifting NHS focus towards prevention to improve healthy life expectancy and reduce regional health disparities within a decade.
Proposing a Child Health Action Plan aimed at fostering the healthiest generation of children ever, the party has plans to ban the sale of highly caffeinated
energy drinks to under-16s.
Addressing concerns from health and education experts about inadequate labeling, drinks with more than 150mg of caffeine per liter will be restricted from retail
and online sales to minors, with enforcement through trading standards.
Labour leader underscores the significance of children's health as a national wellbeing indicator.
He criticises the current government for its short-term approach, which he claims has led to deteriorating health among the nation's children.
The Green Party has previewed its upcoming manifesto with a bold proposal for the National Health Service (NHS) and social care system, promising an
unprecedented level of investment to restore and enhance these critical services.
By 2030, the Greens aim to inject over £50 billion annually into health and social care, accompanied by an additional £20 billion capital investment to modernise
healthcare infrastructure.
Green Party Co-Leader Adrian Ramsay emphasised the urgency of these reforms, stating, "Our NHS is at breaking point following 14 years of underfunding."
"Patients are stuck in hospital corridors, people can't see their GP or NHS dentist when they need to, and staff are severely overstretched."
The manifesto highlights a comprehensive approach to revitalising the NHS, including: